PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
CCENT/2009/13 - Merck / Medicult
Acquired
MediCult
Description
a Danish-registered company quoted on the Oslo Stock Exchange; it specialises in in-vitro fertilisation and assisted reproductive techniques.
Acquiring
Merck KGaA
Description
is the holding company of an international chemical and pharmaceutical group with its headquarters in Germany. The activities of the Merck Group in the pharmaceutical sector include the production of prescription and over-the-counter medicines in various areas, in particular in the treatment of fertility problems. The group has a presence in Portugal through its subsidiary Merck SA;
Sector
  • Health & Pharmaceutical
Activity (NACE)
  • Q86 - Human health activities
Applicable legislation
Art. 9(1)(a) (Law 18)
Notification thresholds
Market share
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Case description
Notified on 20 April 2009, the present merger operation consists of the acquisition by the company Merck KGaA (henceforth "Merck"), through its subsidiary Merck BV, of exclusive control of the company MediCult a/s (henceforth "MediCult"), as a result of the acquisition of its registered capital, within the scope of a takeover bid on the Oslo Stock Exchange.
Timeline
2009-06-04
Phase I Decision - COMPETITION AUTHORITY announces that the procedure initiated to assess Merger Operation No. 13/2009 (Merck / MediCult) has been terminated
2009-04-27
Publication of the announcement
Click here to see your activities